Poplar Therapeutics
PrivateLast Round
Series A
Extension
Mar 3, 2026
Total Funding Raised
$95M
Company Overview
Poplar Therapeutics is a clinical-stage immunology company developing a new class of anti-IgE therapy to treat food allergy and other atopic conditions.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Precision Medicine, Drug Discovery
Business Model
B2B
Customer Profile
Revenue Share, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Poplar Therapeutics Comps
Public and private peers based on sector, stage, and business model.
Poplar Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A Extension | Mar 3, 2026 | ||||
| Series A | Jan 8, 2026 |
Poplar Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Janus Henderson Group | Series A Extension |
| RA Capital Management | Series A Extension |
| Vida Ventures | Series A Extension, Series A |
| ArrowMark Partners | Series A Extension |
| Platanus Ventures | Series A |
| SR One | Series A Extension, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 8, 2026
$50M Series A round completed.
Poplar Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Poplar Therapeutics's valuation, stock price, and market status.
